Bimekizumab

Common brands: Bimzelx, Methotrexate, Vitamin D, Cosentyx, Rasuvo

Top reporter: Ucb, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Interleukin-17A Antagonist [EPC]GLP-1 Receptor Agonist [EPC]Provitamin D2 Compound [EPC]
16,071
Total Reports
13,341
Serious Reports
116
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.72%)

Patient Demographics

Male
1,661
Female
2,587

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Bimekizumab.

# Reaction Reports % of Total
1 PRODUCT DOSE OMISSION ISSUE 2,604
12.2%
2 PSORIASIS 2,019
9.5%
3 DRUG INEFFECTIVE 1,487
7.0%
4 PSORIATIC ARTHROPATHY 1,391
6.5%
5 OFF LABEL USE 1,202
5.6%
6 HIDRADENITIS 1,191
5.6%
7 INJECTION SITE PAIN 960
4.5%
8 CONDITION AGGRAVATED 911
4.3%
9 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 766
3.6%
10 THERAPY INTERRUPTED 735
3.4%
11 PRODUCT AVAILABILITY ISSUE 704
3.3%
12 INCORRECT DOSE ADMINISTERED 571
2.7%
13 PAIN 568
2.7%
14 ORAL CANDIDIASIS 559
2.6%
15 FATIGUE 532
2.5%
16 PRURITUS 502
2.4%
17 HEADACHE 477
2.2%
18 RASH 415
1.9%
19 INSURANCE ISSUE 390
1.8%
20 DIARRHOEA 346
1.6%
21 CANDIDA INFECTION 344
1.6%
22 ARTHRALGIA 335
1.6%
23 NO ADVERSE EVENT 296
1.4%
24 DEVICE ISSUE 295
1.4%
25 ADVERSE DRUG REACTION 293
1.4%
26 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 291
1.4%
27 ANKYLOSING SPONDYLITIS 285
1.3%
28 NASOPHARYNGITIS 282
1.3%
29 ILLNESS 281
1.3%
30 DEPRESSION 280
1.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.